Lamivudine
Links shared publicly online about this topic
Infectious Dis. Medical News about Lamivudine
mdlinx.com — “Abacavir/lamivudine combination in the treatment of HIV: a review” View full resource at mdlinx.com
Most Recently Shared on February 25, 2010 at 10:00 am By:
I/D Abacavir/lamivudine combination in the treatment of HIV: a review: Therapeutics and Clinical Risk Management http://bit.ly/aS5Q0v
Ob/Gyn Medical News about Lamivudine
mdlinx.com — “Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus: A Systematic Review and Meta-Analysis” View full resource at mdlinx.com
Most Recently Shared on June 28, 2010 at 5:38 pm By:
Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus: A Systematic Review and ... http://bit.ly/bxVL4I #OBG
Oncology Article | Anthracyclines Breast Neoplasms Lamivudine Chemotherapy, Adjuvant
mdlinx.com — “Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy” View full resource at mdlinx.com
Most Recently Shared on February 4, 2011 at 7:36 am By:
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients r... http://bit.ly/dVa50m #oncology
FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine and Zidovudine Tablets, 30 mg/60 mg.” View full resource at news-medical.net
Most Recently Shared on January 20, 2011 at 2:21 pm By:
HIV/AIDS News: FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA: Mylan In... http://bit.ly/dXASt0
Treatment for HBV infection with entecavir followed by lamivudine results in virologic rebound
news-medical.net — “A two-year trial of entecavir followed by lamivudine (LAM) in patients with chronic hepatitis B virus (HBV) infection resulted in a virologic rebound rate of 24% and 12% drug-resistance rate. Patients who continued on entecavir therapy throughout the study period had undetectable HBV DNA at the two-year endpoint. Details of this trial are published in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.” View full resource at news-medical.net
Most Recently Shared on April 1, 2011 at 4:59 am By:
Treatment for HBV infection with entecavir followed by lamivudine results in virologic rebound: A two-year trial... http://bit.ly/fPi8Wf
Is it safe to take creatine with Lamivudine + Zidovudine and efavirenz? - Forum on Nutrition and Exercise
thebody.com — “I am glad you are regaining control of your health after adjusting from the shock of your HIV diagnosis. As you know, we can live long and healthy lives, and many of us become even more motivated...” View full resource at thebody.com
Most Recently Shared on August 11, 2011 at 4:01 pm By:
Ask the HIV/AIDS Experts: "Is It OK to Take Creatine With My HIV Meds?" http://bit.ly/nc3ue9 #supplement
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Lamivudine And Zidovudine Tablets, 30 Mg/60 Mg
medicalnewstoday.com — “Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency” View full resource at medicalnewstoday.com
Most Recently Shared on January 21, 2011 at 5:05 pm By:
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Lamivudine And Zidovudine Tablets, 30 Mg/60 Mg http://mnt.to/3QhS #hivaids
Approval of Generic Formulation of Lamivudine and Zidovudine Tablets, 150 mg/300 mg - The Body
thebody.com — “On May 25, 2011, FDA granted approval for a generic formulation fixed dose combination of lamivudine and zidovudine tablets, 150 mg/300 mg, a two ...” View full resource at thebody.com
Most Recently Shared on May 27, 2011 at 10:01 pm By:
Approval of Generic Formulation of Lamivudine and Zidovudine Tablets, 150 mg/300 mg http://bit.ly/jloNoa #hiv #aids #combivir
Gastroenterology News - Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis |3975466
mdlinx.com — “Gastroenterology Medical Article: Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis” View full resource at mdlinx.com
Most Recently Shared on March 19, 2012 at 6:43 pm By:
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decom... http://t.co/MOGxHFxV #GI
Gastroenterology News - Reassessing the role for lamivudine in chronic hepatitis B infection: A four-year cohort analysis |3976098
mdlinx.com — “Gastroenterology Medical Article: Reassessing the role for lamivudine in chronic hepatitis B infection: A four-year cohort analysis” View full resource at mdlinx.com
Most Recently Shared on March 16, 2012 at 10:06 am By:
Reassessing the role for lamivudine in chronic hepatitis B infection: A four-year cohort analysis: Canadian ... http://t.co/UYuJtVUv #GI
Infectious Disease News - Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis |3975466
mdlinx.com — “Infectious Disease Medical Article: Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis” View full resource at mdlinx.com
Most Recently Shared on March 19, 2012 at 12:16 pm By:
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decom... http://t.co/UWyKOgho #ID
Gastroenterology Article | Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance
mdlinx.com — “Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance” View full resource at mdlinx.com
Most Recently Shared on September 21, 2011 at 11:43 am By:
Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine re... http://t.co/oBIw3PJc #GI
IngentaConnect Efavirenz/lamivudine/zidovudine: Immune reconstitution syndrome i...
ingentaconnect.com — “IngentaConnect Efavirenz/lamivudine/zidovudine: Immune reconstitution syndrome i...” View full resource at ingentaconnect.com
Most Recently Shared on July 4, 2010 at 8:32 am By:
Efavirenz/lamivudine/zidovudine: Immune reconstitution syndrome in an HIV-positive patient with tuberculosis: case... http://bit.ly/aHUipj
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B: This... http://bit.ly/abLQ0q
www3.interscience.wiley.com — “High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B: This... http://bit.ly/abLQ0q” View full resource at www3.interscience.wiley.com
Most Recently Shared on July 16, 2010 at 12:12 pm By:
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B: This... http://bit.ly/abLQ0q
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B - Mendes-Correa - 2010 - Journal of Medical Virology - Wiley Online Library
onlinelibrary.wiley.com — “High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B - Mendes-Correa - 2010 - Journal of Medical Virology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on August 9, 2010 at 4:38 pm By:
High frequency of lamivudine resistance mutations in Brazilian patients coâ€*infected with HIV and hepatitis B: Ab... http://bit.ly/9zpOM9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

